LYTALINK
Intra-cellular Therapies, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90154881 |
| Registration Number | 6437739 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Attorney Name | Cory Poker |
| Attorney Docket Number | TM-05-IT-DES |
Timeline
| 2020-04-01 | Date of First Use |
| 2020-09-02 | Application Filed |
| 2020-09-29 | Location: NEW APPLICATION PROCESSING |
| 2020-09-29 | Status: Live/Pending |
| 2020-10-08 | Transaction Date |
| 2021-08-03 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  INTRA-CELLULAR THERAPIES, INC. |
| Address | Suite 900 430 East 29th Street New York DE 10016 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
 Application | MULTI | 2020-09-02 |
 Drawing | JPEG | 2020-09-02 |
| Specimen | JPEG | 2020-09-02 |
Design Search Codes
| 050308 | More than one leaf, including scattered leaves, bunches of leaves not attached to branches |
| 270304 | Plants forming letters or numerals |
Attorney of Record
Good, Services, and Codes
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| Type Code | Type |
|---|---|
| CC0000 | The color(s) teal, lavender is/are claimed as a feature of the mark. |
| CC0000 | The color(s) teal, dark teal, light teal and lavender is/are claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-10-07 | 1 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2020-10-08 | 2 MDSM E:E-Mail |
| ASSIGNED TO EXAMINER | 2021-01-07 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-01-07 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-01-07 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-01-07 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-04-08 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-04-08 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-04-09 | 9 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2021-04-12 | 10 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2021-04-12 | 11 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-04-12 | 12 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2021-04-12 | 13 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-04-12 | 14 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-04-28 | 15 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-05-18 | 16 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-05-18 | 17 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2021-08-03 | 18 R.PR A:Allowance for Publication |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LYTALINK 90154881 not registered Live/Pending |
INTRA-CELLULAR THERAPIES, INC. 2020-09-02 |
 LYTALINK 90154837 not registered Live/Pending |
INTRA-CELLULAR THERAPIES, INC. 2020-09-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 